8-week lower-limb resistance program for young people with Charcot–Marie–Tooth disease
Official title: Effects of a Resistance Exercise Training Program on Skeletal Muscle Quality, Functional Capacity, and Quality of Life in Young Individuals With and Without Hereditary Sensorimotor Polyneuropathy
Run by Universidad de La Frontera · NCT07152197 · Data updated 2026-11-12
This program will test whether 8 weeks of supervised lower-limb resistance exercises help improve muscle quality, functional ability, and quality of life in 15–29 year olds with and without Charcot–Marie–Tooth disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 29 Years |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Universidad de La Frontera Academic / other |
| Locations | 2 sites (Temuco, La Araucanía and 1 other locations) |
| Status | Recruiting |
| Started | September 20, 2025 |
| Main results expected | July 20, 2026 |
| Study ends | September 20, 2026 |
| Registry record updated | September 23, 2025 |
| Trial ID | NCT07152197 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are community-dwelling men or women aged 15–29 with a confirmed diagnosis of hereditary sensorimotor polyneuropathy (or healthy controls for comparison) who have at least active ankle movement to 0° dorsiflexion and can attend supervised sessions.
✕Probably not a fit
People with severe osteoarticular or mobility limitations that prevent safe exercise, recent related surgery, uncontrolled chronic disease, intellectual disability preventing participation, current resistance training within six months, or use of muscle-regulating supplements are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will enroll two groups of participants aged 15–29 — young people with hereditary sensorimotor polyneuropathy (Charcot–Marie–Tooth) and matched healthy controls — and deliver a supervised progressive lower-limb resistance training program three times per week for eight weeks. Primary outcomes are changes in tibialis anterior muscle thickness and echogenicity measured by ultrasonography; secondary outcomes include muscle architecture (fascicle length, pennation angle), body composition, functional capacity tests, and quality-of-life measures. Outcomes will be compared to baseline within each participant and between the HSPN and control groups to determine relative improvements. The intervention excludes people with contraindicating mobility or medical conditions and those currently engaged in resistance training or using muscle-altering supplements.
Why it matters
Potential benefit: If successful, the program could offer a low-cost, non-drug approach to improve leg muscle quality, mobility, and daily functioning for young people with CMT.
How similar studies have gone: Resistance training has shown benefits for strength and function in other populations and limited CMT reports suggest potential gains, but few controlled lower-limb ultrasound-based studies in young adults with CMT exist, so the approach is promising but not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men or women between 15 and 29 years of age with a diagnosis of hereditary sensorimotor polyneuropathy (HSPN) in any of its subtypes, living in the community (for experimental group). * Healthy men or women between 15 and 29 years of age living in the community (for control group). * Having active ankle movement within a range from plantarflexion to at least 0° of ankle dorsiflexion, allowing for strength training. Exclusion Criteria: * Osteoarticular or mobility impairments that prevent safe performance of resistance exercise training (e.g., ankle arthrodesis). * Use of nutritional supplements that may affect skeletal muscle regulation (leucine, glutamine, casein, whey protein, fatty acids, creatine, among others). * Untreated and/or uncontrolled chronic diseases or intellectual disability. * History of surgery * Participation in a resistance exercise training program within the past 6 months.
Where it's running
-
Temuco, Chile
Temuco, La Araucanía, Chile Recruiting -
Universidad de La Frontera
Temuco, La Araucanía, Chile Active not recruiting
Study contacts
- Study coordinator: Fernando J Valenzuela, MSc
- Email: fernando.valenzuela@ufrontera.cl
- Phone: +56950166328
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tremor in Charcot–Marie–Tooth disease
Try to characterize tremor in adults with Charcot–Marie–Tooth (CMT) disease using surface electromyography, accelerometers, a clinical exam and questionnaires to see how tremor affects daily life.
-
Ankle-foot braces versus surgery to improve walking and balance in CMT
This will test whether ankle-foot braces or surgical correction better improve walking, balance, and mobility for people aged 12 to 75 with genetically confirmed Charcot–Marie–Tooth disease.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
New orthopedic devices for treating foot neuropathy in breast cancer patients
This study tests a new foot device to see if it can help breast cancer patients with nerve pain caused by chemotherapy feel better compared to regular shoe inserts and orthopedic treatments.
-
Personalized exercise treatment for adults with rare neuromuscular disorders
This study is testing if a personalized exercise program can help adults with rare neuromuscular disorders improve their balance and physical function better than regular care.
-
Investigating the link between unexplained polyneuropathy and wild-type TTR cardiac amyloidosis
This study is trying to see if people with unexplained nerve problems might also have a heart condition called wild-type TTR cardiac amyloidosis to help diagnose them faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.